MarketInOut Stock Screener Log In | Sign Up
 

Rani Therapeutics Holdings Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Rani Therapeutics Holdings Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization85.14 mln
Float87.99 mln
Earnings Date11/05/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

26.08
Highly suspicious

Relative Strength

9 / 100
Severely lagging

Debt / Equity

0.09
Debt-free

Pre-Tax Margin

-685%
Severely loss-making

ROE

-173
Deeply negative

Business Description

Rani Therapeutics is a clinical-stage biotech company based in San Jose, California, working to replace painful injections with a swallowable capsule that delivers drugs directly into the body. Their core technology, the RaniPill, is designed to work with a wide range of drug types and is currently being tested across several programs targeting conditions such as osteoporosis, psoriatic arthritis, obesity, and inflammatory diseases. The company also has a partnership to develop an obesity treatment and has been building its pipeline since it was founded in 2012.

Key Fundamentals

EPS-0.15
ROE-173
RPS0.04
ROIC-180
ROA-75.97
Interest Cover-28.22
EBITDA, mln-31.49
EV / EBITDA-3.39
EV / EBIT-3.31
Revenue, mln4.88
EV / Revenue21.90

Quote Details

Last 0.6059
Change 0.0183 (3.11%)
Open 0.5977
Volume 286,918
Turnover 173,844
Average Volume 543,475

Financial Ratios

Pre-Tax Profit Margin-685
Leverage Ratio1.55
Current Ratio5.31
Price / Book1.84
Price / Tangible Book1.84
Debt / Equity0.09
Price / Sales28.28

Financial Strength

Altman Z-Score0.16
Piotroski F-Score 5 / 9
Beneish M-Score26.08
Short Ratio13.12
Short % of Float6.45

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.42% 16 / 100   
1 Month -19.11% 19 / 100   
2 Months -11.71% 29 / 100   
6 Months -35.47% 18 / 100   
1 Year -74.96% 10 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog